DE69533485D1 - Neue polypeptide - Google Patents

Neue polypeptide

Info

Publication number
DE69533485D1
DE69533485D1 DE69533485T DE69533485T DE69533485D1 DE 69533485 D1 DE69533485 D1 DE 69533485D1 DE 69533485 T DE69533485 T DE 69533485T DE 69533485 T DE69533485 T DE 69533485T DE 69533485 D1 DE69533485 D1 DE 69533485D1
Authority
DE
Germany
Prior art keywords
pct
pbp
variants
sec
date
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69533485T
Other languages
English (en)
Other versions
DE69533485T2 (de
Inventor
Tanjore Soundararaja Balganesh
Christine Mary Town
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of DE69533485D1 publication Critical patent/DE69533485D1/de
Application granted granted Critical
Publication of DE69533485T2 publication Critical patent/DE69533485T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C12N9/107—1,4-Alpha-glucan branching enzyme (2.4.1.18)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01018—1,4-Alpha-glucan branching enzyme (2.4.1.18), i.e. glucan branching enzyme
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Toxicology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69533485T 1994-11-24 1995-06-21 Neue polypeptide Expired - Fee Related DE69533485T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9404072A SE9404072D0 (sv) 1994-11-24 1994-11-24 Novel polypeptides
SE9404072 1994-11-24
PCT/SE1995/000761 WO1996016082A1 (en) 1994-11-24 1995-06-21 Novel polypeptides

Publications (2)

Publication Number Publication Date
DE69533485D1 true DE69533485D1 (de) 2004-10-14
DE69533485T2 DE69533485T2 (de) 2005-09-22

Family

ID=20396098

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69533485T Expired - Fee Related DE69533485T2 (de) 1994-11-24 1995-06-21 Neue polypeptide

Country Status (13)

Country Link
US (1) US6027906A (de)
EP (1) EP0792284B1 (de)
JP (1) JPH10512439A (de)
CN (1) CN1127516C (de)
AT (1) ATE275579T1 (de)
AU (1) AU3088795A (de)
DE (1) DE69533485T2 (de)
FI (1) FI972215A (de)
GB (1) GB2290792A (de)
HU (1) HUT77487A (de)
NO (1) NO972353L (de)
SE (1) SE9404072D0 (de)
WO (1) WO1996016082A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998018931A2 (en) 1996-10-31 1998-05-07 Human Genome Sciences, Inc. Streptococcus pneumoniae polynucleotides and sequences
US6676943B1 (en) 1997-04-24 2004-01-13 Regents Of The University Of Minnesota Human complement C3-degrading protein from Streptococcus pneumoniae
US20030143635A1 (en) * 2000-06-08 2003-07-31 Astrazeneca Ab Assay for detection of transferase enzyme activity in drug screening
FR2829153B1 (fr) * 2001-09-05 2004-12-31 Aventis Pharma Sa Procede d'identification de composes liant une glycosyl transferase
SE0104102D0 (sv) 2001-12-05 2001-12-05 Astrazeneca Ab New assay
SE0104101D0 (sv) 2001-12-05 2001-12-05 Astrazeneca Ab New assay
GB0823550D0 (en) * 2008-12-24 2009-01-28 Kinasource Ltd Peptide tag and uses thereof
US8182842B1 (en) 2010-11-10 2012-05-22 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Physico-chemical-managed killing of penicillin-resistant static and growing gram-positive and gram-negative vegetative bacteria
CN106085982B (zh) * 2016-08-18 2019-08-13 武汉职业技术学院 青霉素结合蛋白Bt-pbp2X及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0505151A3 (en) * 1991-03-19 1993-04-07 Eli Lilly And Company Preparation of the penicilline binding protein 2a from staphylococcus aureus 27r, purification and use in a resistant-assay
US5508177A (en) * 1993-05-14 1996-04-16 Eli Lilly And Company Process for purification of water soluble penicillin binding protein 2a

Also Published As

Publication number Publication date
DE69533485T2 (de) 2005-09-22
US6027906A (en) 2000-02-22
CN1127516C (zh) 2003-11-12
CN1173182A (zh) 1998-02-11
NO972353D0 (no) 1997-05-22
ATE275579T1 (de) 2004-09-15
FI972215A0 (fi) 1997-05-26
NO972353L (no) 1997-07-01
EP0792284A1 (de) 1997-09-03
SE9404072D0 (sv) 1994-11-24
GB9513306D0 (en) 1995-09-06
GB2290792A (en) 1996-01-10
FI972215A (fi) 1997-05-26
JPH10512439A (ja) 1998-12-02
HUT77487A (hu) 1998-05-28
EP0792284B1 (de) 2004-09-08
AU3088795A (en) 1996-06-17
WO1996016082A1 (en) 1996-05-30

Similar Documents

Publication Publication Date Title
NZ323795A (en) Isolated nucleic acid molecules encoding AUR-1 (aurora-1) and AUR-2 polypeptides
BG100771A (en) Hematopoeic protein and ways and methods for its preparation
DK1005540T3 (da) IKK-beta-proteiner, nukleinsyrer og fremgangsmåder
ATE370961T1 (de) Reinigung von antikörpern durch ionenaustauschchromatographie
NZ296748A (en) Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
PL374311A1 (en) Methods for purifying protein
DK0930366T3 (da) Bindingsdomæner i Delta-proteiner
DE69433301D1 (de) Methoden zur erhöhung der biologischen aktivität von chemokinen
BR9713727A (pt) Corpos oleosos e proteìnas associados como matrizes de afinicade.
ATE275579T1 (de) Neue polypeptide
ATE350472T1 (de) Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen
DE69435020D1 (en) Protein-tyrosin-phosphatase ptp-s31
DE69504808T2 (de) Corticotropin freisetzende rezeptoren des faktor 2
ATE419361T1 (de) Menschliche monoklonale antikörper spezifisch für antigen e2 des hepatitis c virus
EP1005539A4 (de) Ikk-alpha proteine, nukleinsäuren und verfahren
WO1994026891A3 (en) Purified mammalian flt3 ligands and agonists and antagonists thereof
DE69534471D1 (de) Peptide, die fähig sind die sh3-domäne des gap-proteins zu binden, ihre kodierende dns, ihre zubereitung und verwendung
TR200003624T2 (tr) Yeni poli(ADP-RİBOZ) polimeraz-genleri
DE69728897D1 (de) Saeugetierchemokine
ATE432349T1 (de) Modifizierte hämoglobinähnliche verbindungen und verfahren zu deren reinigung
GB9800378D0 (en) Proteome analysis
DE69733026D1 (de) Cyclin e spezifische konstrukte und komplexe
WO2000017363A3 (en) Interleukin-1 like molecule: interleukin-1-zeta; nucleic acids, polypeptides, antibodies, their uses
DE59611353D1 (de) Transketolase-verwandtes protein

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee